Cardiac transplantation of skeletal myoblasts for heart failure

Minerva Cardioangiologica

Volumn 51, Issue 2, 2003, Pages 227-243

  Van Den Bos, E J ^a,b   Taylor, D A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardio myoplasty; Cell transplantation; Heart failure, congestive; Myocardial injury; Stem cells

Indexed keywords

ANIMAL MODEL; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONGESTIVE HEART FAILURE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART TRANSPLANTATION; INCIDENCE; MORBIDITY; MORTALITY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; OUTCOMES RESEARCH; PREVALENCE; REVIEW; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION;

EID: 0038690053     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'insuffisance cardiaque avancee en Lorraine. J Am Coll Cardiol 1999;33:734-42.
2. Marelli D, Desrosiers C, El-Alfy M, Kao RL, Chiu RCJ. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992;1:383-90.
3. Armoundas AA, Wu R, Juang G, Marban E, Tomaselli GF. Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 2001;92:213-30.
4. Soonpaa M, Kim KK, Pajak L, Franklin M, Field LJ. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 1996;271:H2183-9.
5. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998;83:15-26.
6. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
7. Soonpaa M, Field L. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1996;272:2183-9.
8. Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A 2001;98:10308-13.
9. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002;90:634-40.
10. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
11. Mauro A. Satellite cells of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9:493-7.
12. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 1998;95:13726-31.
13. Mc-Kinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavillio F, Goodell MA. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A 2002;99:134-9.
14. Zammit PS, Beauchamp JR. The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 2001;68:193-204.
15. Grounds MA, White JD, Rosenthal N, Bogoyevitch MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 2002;50:589-610.
16. Baroffio A, Hamann M, Bemheim L, Bochaton-Piallat ML, Gabbiani G, Bader C. Identification of self renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 1996;60:47-57.
17. Blanton JR, Grant AL, McFarland DC, Robinson JP, Bidwell CA. Isolation of two populations of myoblasts from porcine skeletal muscle. Muscle Nerve 1999;22:43-50.
18. Deasy BM, Qu-Peterson Z, Greenberger JS, Huard J. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 2002;20:50-60.
19. Chakravarthy MV, Spangenburg E, Booth FW. Culture in low levels oxygen enhances in vitro proliferation potential of satellite cells from old skeletal muscle. Cell Mol Life Sci 2001;58:1-9.
20. Kawada H, Ogawa M. Hematopoietic progenitors and stem cells in murine muscle. Blood Cells Dis 2001;27:605-9.
21. Jackson K, Mi T, Goodell M. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 1999;96:14482-6.
22. Csete M, Walikonis J, Slawny N, Wei Y, Korsnes S, Doyle JC et al. Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture. J Cell Physiol 2001;189:189-96.
23. Young He, Wright R, Mancini ML, Lucas PA, Reagan CR, Black AC. Bioactive factors affect proliferation and phenotypic expression in progenitor and pluripotent stem cells. Wound Repair Regen 1998;6:65-75.
24. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62.
25. Goldring K, Jones GE, Thiagarajah R, Watt DJ. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J Cell Sci 2002;115:355-66.
26. Watt DJ, Jones GE, Goldring K. A factor within myoblast conditioned medium results in a high myogenic conversion in clones of cells derived from the mouse dermis. Cell Transplant 1998;8:214.
27. Lattanzi L, Salvatori G, Coletta M, Sonnino C, Cusella De Angelis MG, Gioglio L et al. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 1998;101:2119-28.
28. Beyer EC, Kistler J, Paul DL, Goodenough DA. Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol 1989;108:595-605.
29. Angst BD, Khan LU, Severs NJ, Whitely K, Rothery S, Thompson RP et al. Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ Res 1997;80:88-94.
30. Balogh S, Naus CCG, Merrifield PA. Expression of gap junctions in cultured rat L6 cells during myogenesis. Dev Biol 1993;155:351-60.
31. Gibbs CL, Barclay CJ. Cardiac efficiency. Cardiovasc Res 1995;30:627-34.
32. Pette D. Fiber transformation and fiber replacement in chronically stimulated muscle. J Heart Lung Transplant 1992;11:S299-305.
33. Pin C, Merrifield PA. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev Biol 1997;188:147-66.
34. Edom F, Mouly V, Barbet JP, Fiszman MY, Butler-Browne GS. Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains. Dev Biol 1994;164:219-29.
35. Kelly AM. Satellite cells and myofiber growth in the rat soleus and extensor digitorum longus muscles. Dev Biol 1978;65:1-10.
36. Gibson MC, Schultz E. The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digtorum longus muscles. Anat Rec 1982;202:329.
37. Taylor DA, Silvestry SC, Bishop SP, Annex BH, Lilly RE, Glower DD et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Physicians 1997;109:245-53.
38. Neumeyer AM, DiGregorio DM, Brown RH. Arterial delivery of myoblasts to skeletal muscle. Neurology 1992;42:2258-62.
39. McGeachie JK, Grounds MD. Cell proliferation in denervated skeletal muscle: does it provide a pool of potential circulating myoblasts? Bibl Anat 1992;29:173-93.
40. Dib N, Diethrich EB, Campbell A, Goodwin N, Robinson B, Gilbert J et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 2002;9:313-9.
41. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33.
42. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997;3:970-7.
43. Huard J, Acsadi G, Jani A, Massie B, Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994;5:949-58.
44. Beauchamps JR, Morgan JE, Pagel CN, Partridge TA. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 1994;18:261.
45. Guerette B, Asselin I, Skuk D, Entman M, Tremblay JP. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant 1997;6:101-7.
46. Tremblay JP, Guerette B. Myoblast transplantation: a brief review of the problems and of some solutions. Basic Appl Myol 1997;7:221-30.
47. Qu Z, Balkir L, van Deutekom JCT, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve myoblast transfer therapy. J Cell Biol 1998; 142:1257-67.
48. Suzuki K, Smolenski RT, Jayakumar J, Murtuza B, Brand NJ, Yacoub MH. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 2000;102(19 Suppl 3):III216-21.
49. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1-15.
50. Suzuki K, Murtuza B, Smolenski RT. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 2001;104(12 Suppl 1):I207-12.
51. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-9.
52. Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993;92:1548-54.
53. Robinson SW, Cho PW, Levitsky HI, Olson JL, Hruban RH, Acker MA et al. Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: longterm survival and phenotypic modification of implanted myoblasts. Cell Transplant 1996;5:77-91.
54. Rash JE, Fambrough DM. Ultrastructural and electrophysiologic correlates of cell coupling and cytoplasmic fusion during myogenesis in vitro. Dev Biol 1973;30:166-80.
55. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
56. Atkins BZ, Lewis CW, Kraus WE, Hutcheson KA, Glower DD, Taylor DA. Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. Ann Thorac Surg 1999;67:124-9.
57. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-5.
58. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-23.
59. Chachques J, Rajnoch C, Berrebi A, Borenstein N, Shen M, Attellis N et al. Cellular therapy reverses myocardial dysfunction. Proceedings of the 80th Annual Meeting of the American Association. Toronto: American Association for Thoracic Surgery; 2000.
60. Jain M, DerSimonian H, Brenner DA. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001;103:1920-7.
61. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001;71:844-51.
62. Ellis MJ, Emani SM, Colgrove SL, Glower DD, Taylor DA. Cell dosage is critical for improved contractility following cellular cardiomyoplasty. Circulation 2001;104:II-336.
63. Pouzet B, Ghostine S, Vilquin JT, Garcin I, Scorsin M, Hagege AA et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 2001;104(12 Suppl 1):1223-8.
64. Suzuki K, Murtuza B, Heslop L, Morgan JE, Smolenski RT, Suzuki N et al. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg 2002;123:984-92.
65. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation 2000;102(19 Suppl 3):111210-5.
66. Scorsin M, Hagege AA, Dolizy I, Marotte F, Mirochnik N, Copin H et al. Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 1998;98(19 Suppl):II151-5; discussion 11155-6.
67. Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intracoronary infusion of skeletal myoblasts improved cardiac function in doxorubicin-induced heart failure. Circulation 2001;104(12 Suppl 1):1213-7.
68. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-40.
69. Atkins BZ, Hueman MT, Meuchel JM, Cottman MJ, Hutcheson KA, Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 1999;18:1173-80.
70. Atkins BZ, Hueman MT, Meuchel J, Hutcheson KA, Glower DD, Taylor DA. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res 1999;85:234-42.
71. Silvestry SC, Taylor DA, Lilly RE, Atkins BZ, Marathe US, Davis JW et al. The in vivo quantification of myocardial performance in rabbits: a model for evaluation of cardiac gene therapy. J Mol Cell Cardiol 1996;28:815-23.
72. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000;9:359-68.
73. Hagege AA, Vilquin JT, Bruneval P, Menasche P. Regeneration of the myocardium: a new role in the treatment of ischemic heart disease? Hypertension 2001;38:1413-5.
74. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52.
75. Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, Long TI et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002;105:1720-6.
76. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997;3:1337-45.
77. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
78. Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
79. Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80.